Tirzepatide (GIP/GLP-1) Weight Loss in Studio City
Tirzepatide is a dual GIP/GLP-1 receptor agonist, the molecule behind Mounjaro and Zepbound. By activating two gut-hormone receptors instead of one, it curbs appetite and supports metabolic health on two fronts: in clinical trials, patients lost up to ~20% of their body weight, more on average than with semaglutide.
At TONIIK, tirzepatide comes with what an online prescription mill can’t offer: baseline labs, NP-managed dose titration and body-composition tracking, adjusted month by month.
How TONIIK's Tirzepatide Program Works
Tirzepatide works by mimicking two of your body’s own incretin hormones: GIP and GLP-1. The combination slows stomach emptying, quiets “food noise,” reduces appetite and improves how your body handles blood sugar. That dual mechanism is why, in head-to-head clinical trials, tirzepatide produced greater average weight loss than semaglutide, and why some patients who plateaued or felt poorly on semaglutide do better after switching.
Every program starts with labs. Before your first dose we run a Weight Loss Basic Panel or Complete Panel, covering thyroid, metabolic markers, A1c and more. That way your protocol is built on data, not guesswork. See all lab panels.
Then your NP manages titration. Weekly injections start low and increase only when your body is ready. Side effects get managed, not ignored: dose pacing, timing, nutrition strategy. We track body composition, not just scale weight, so you preserve muscle while you lose fat.
Microdosing for the right candidates. Our tirzepatide microdose protocol uses smaller-than-standard doses for patients who want appetite regulation and metabolic support with fewer side effects. It’s popular with patients targeting 10 to 20 lbs rather than 50+.
What your program includes
- Practitioner-supervised tirzepatide protocol, standard or microdose
- Required baseline labs: Weight Loss Basic Panel or Complete Panel
- Monthly check-ins, dose titration and body-composition tracking
Your practitioner confirms which protocol and which panel you need at the consultation, and quotes the whole program month by month before you start.
Not sure tirzepatide is your molecule? Compare all medical weight loss programs at TONIIK (semaglutide, tirzepatide and retatrutide) and let the consult and your labs decide.
Related treatments: Medical weight loss programs · Semaglutide for weight loss · Lab panels
FAQ
Semaglutide activates one receptor (GLP-1); tirzepatide activates two (GIP + GLP-1). In clinical trials, tirzepatide produced greater average weight loss (up to ~20% of body weight vs ~15% for semaglutide), and some patients tolerate it better. Semaglutide has the longer track record. We recommend based on your labs, history and goals.
It depends on whether you run the standard or the microdose protocol, and which baseline lab panel you start with. Your practitioner walks through both at the consultation and quotes the full monthly program upfront, before you commit to anything.
The most common are nausea, constipation and fatigue, usually during dose increases. Many patients find tirzepatide gentler than semaglutide at comparable results. Our NP-managed titration (and microdose protocols) exist specifically to keep side effects manageable.
Yes. Baseline labs, either the Basic Panel or the Complete Panel, check thyroid, metabolic markers, A1c and more. That catches issues that change the right treatment plan. It’s what separates medical weight loss from an online prescription.
Appetite reduction typically starts within the first few weeks. Meaningful weight change builds over months as your dose titrates up. In clinical trials, maximum results developed over a year or more. We track body composition monthly so you can see progress beyond the scale.
